← Every applicant
Rubicon Research FDA Approvals
52 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| SPIRONOLACTONE AND HYDROCHLOROTHIAZIDENew drugSep 10, 2026TABLET, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugJul 17, 2026CAPSULE, ORAL |
| PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDENew drugJun 23, 2026SYRUP, ORAL |
| CLONAZEPAMNew drugMay 21, 2026TABLET, ORALLY DISINTEGRATING, ORAL |
| IBUPROFENNew drugMar 5, 2026SUSPENSION, ORAL |
| CETIRIZINE HYDROCHLORIDENew drugFeb 25, 2026SOLUTION, ORAL |
| CHLORPROMAZINE HYDROCHLORIDENew drugOct 10, 2025CONCENTRATE, ORAL |
| FLUTICASONE PROPIONATENew drugAug 15, 2025SPRAY, METERED, NASAL |
| VALSARTANNew drugJun 5, 2025SOLUTION, ORAL |
| FLUTICASONE PROPIONATENew drugJun 5, 2025SPRAY, METERED, NASAL |
| TOPIRAMATENew drugMay 27, 2025CAPSULE, ORAL |
| GUANFACINE HYDROCHLORIDENew drugApr 15, 2025TABLET, EXTENDED RELEASE, ORAL |
| LOPRESSORNew drugApr 10, 2025SOLUTION, ORAL |
| IVERMECTINNew drugJan 22, 2025TABLET, ORAL |
| IPRATROPIUM BROMIDENew drugJan 14, 2025SPRAY, METERED, NASAL |
| BUMETANIDENew drugDec 27, 2024TABLET, ORAL |
| BACLOFENNew drugDec 6, 2024SOLUTION, ORAL |
| IPRATROPIUM BROMIDENew drugNov 15, 2024SPRAY, METERED, NASAL |
| CLOMIPHENE CITRATENew drugNov 12, 2024TABLET, ORAL |
| TRANEXAMIC ACIDNew drugJun 11, 2024TABLET, ORAL |
| CARBIDOPA AND LEVODOPANew drugJun 4, 2024TABLET, EXTENDED RELEASE, ORAL |
| OXCARBAZEPINENew drugMar 5, 2024TABLET, ORAL |
| HALOPERIDOLNew drugJan 31, 2024CONCENTRATE, ORAL |
| GUANFACINE HYDROCHLORIDENew drugOct 17, 2023TABLET, ORAL |
| GLIPIZIDENew drugOct 3, 2023TABLET, ORAL |
| NORTRIPTYLINE HYDROCHLORIDENew drugAug 15, 2023SOLUTION, ORAL |
| LITHIUM CITRATENew drugAug 14, 2023SYRUP, ORAL |
| DIHYDROERGOTAMINE MESYLATENew drugJun 22, 2023SPRAY, METERED, NASAL |
| POTASSIUM CHLORIDENew drugJun 16, 2023TABLET, EXTENDED RELEASE, ORAL |
| DICLOFENAC SODIUMNew drugMay 11, 2023TABLET, DELAYED RELEASE, ORAL |
| AMITRIPTYLINE HYDROCHLORIDENew drugMay 1, 2023TABLET, ORAL |
| CEVIMELINE HYDROCHLORIDENew drugApr 6, 2023CAPSULE, ORAL |
| LIDOCAINE HYDROCHLORIDENew drugMar 28, 2023SOLUTION, ORAL |
| BACLOFENNew drugFeb 22, 2023INJECTABLE, INTRATHECAL |
| LOPERAMIDE HYDROCHLORIDENew drugJan 26, 2023CAPSULE, ORAL |
| GABAPENTINNew drugJan 18, 2023SOLUTION, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugDec 14, 2022TABLET, ORAL |
| ARIPIPRAZOLENew drugOct 27, 2022SOLUTION, ORAL |
| CARBIDOPA AND LEVODOPANew drugSep 21, 2022TABLET, ORAL |
| OXCARBAZEPINENew drugAug 30, 2022SUSPENSION, ORAL |
| ACYCLOVIRNew drugAug 18, 2022SUSPENSION, ORAL |
| POTASSIUM CHLORIDENew drugJul 25, 2022TABLET, EXTENDED RELEASE, ORAL |
| ISOSORBIDE DINITRATENew drugJul 8, 2022TABLET, ORAL |
| PRIMIDONENew drugJun 28, 2022TABLET, ORAL |
| POTASSIUM CHLORIDENew drugMar 24, 2022FOR SOLUTION, ORAL |
| PREGABALINNew drugMar 22, 2022TABLET, EXTENDED RELEASE, ORAL |
| TRIAMTERENE AND HYDROCHLOROTHIAZIDENew drugFeb 23, 2022TABLET, ORAL |
| POTASSIUM CHLORIDENew drugJan 13, 2022SOLUTION, ORAL |
| METOLAZONENew drugAug 20, 2021TABLET, ORAL |
| ACETAZOLAMIDENew drugAug 19, 2021TABLET, ORAL |
| LABETALOL HYDROCHLORIDENew drugAug 18, 2021TABLET, ORAL |
| NITROGLYCERINNew drugMay 3, 2021TABLET, SUBLINGUAL |